Research programme: small molecule therapeutics - Kumquat Biosciences
Alternative Names: Small molecule inhibitors - Kumquat Biosciences; Small molecules - Kumquat BiosciencesLatest Information Update: 28 Aug 2025
At a glance
- Originator Kumquat Biosciences
- Class Antineoplastics; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Aug 2025 No recent reports of development identified for research development in Solid-tumours in USA
- 29 Jul 2021 Kumquat Biosciences and Loxo Oncology enters into discovery, development and commercialisation agreement for small molecules
- 29 Jul 2021 Early research in Solid tumours in USA (unspecified route)